Publicaciones 2015
1. Vallejo C; Montesinos P; Polo M; Cuevas B; Morado M; Rosell A; Xicoy B; Diez JL; Salamero O; Cedillo A; Martinez P; Rayon C. Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis. ANNALS OF HEMATOLOGY. 2015; 94(6) 947-954. FI: 3,022. Cuartil: 2. (Article).
2. Font P; Loscertales J; Soto C; Ricard P; Munoz-Novas C; Martin-Clavero E; Lopez-Rubio M; Garcia-Alonso L; Callejas M; Bermejo A; Benavente C; Ballesteros M; Cedena T; Calbacho M; Urbina R; Villarrubia J; Gil S; Bellon JM;. Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts. ANNALS OF HEMATOLOGY. 2015; 94(4) 565-573. FI: 3,022. Cuartil: 2. (Article).
3. Sanchez PL; Fernandez-Santos ME; Costanza S; Climent AM; Moscoso I; Gonzalez-Nicolas MA; Sanz-Ruiz R; Rodriguez H; Kren SM; Garrido G; Escalante JL; Bermejo J. Acellular human heart matrix: A critical step toward whole heart grafts. BIOMATERIALS. 2015; 61. 279-289. FI: 8,387. Cuartil: 1. (Article).
4. Parody R; Martino R; de la Camara R; Garcia-Noblejas A; Esquirol A; Garcia-Cadenas I; Villaescusa T; Caballero D; Rovira M; Fernandez-Aviles F; Marquez-Malaver FJ; Espigado I; Castilla-Llorente C; Heras I; Cabero MA; Cabrera JR; Barba P; Valcarcel D; Sanc. Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time. BONE MARROW TRANSPLANTATION. 2015; 50(2) 274-281. FI: 3,636. Cuartil: 2. (Article).
5. Horstmann K; Boumendil A; Finke J; Finel H; Kanfer E; Milone G; Russell N; Bacigalupo A; Chalandon Y; Diez-Martin JL; Ifrah N; Chacon MJ; Dreger P. Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party. BONE MARROW TRANSPLANTATION. 2015; 50(6) 790-794. FI: 3,636. Cuartil: 2. (Article).
6. Casado LF; Garcia-Gutierrez JV; Massague I; Giraldo P; Perez-Encinas M; de Paz R; Martinez-Lopez J; Bautista G; Osorio S; Requena MJ; Palomera L; Penarrubia MJ; Calle C; Hernandez-Rivas JA; Burgaleta C; Maestro B; Garcia-Ormena N; Steegmann JL. Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months. CANCER MEDICINE. 2015; 4(7) 995-1002. FI: 2,915. Cuartil: 3. (Article).
7. De la Fuente-Gonzalo F; Nieto JM; Ricard P; Anguita J; Martinez R; Cervera A; Villegas A; Gonzalez FA; Ropero P. Hb Cervantes, Hb Maranon, Hb La Mancha and Hb Goya: Description of 4 new haemoglobinopathies. CLINICAL BIOCHEMISTRY. 2015; 48(10-11) 662-667. FI: 2,382. Cuartil: 2. (Article).
8. Valerio M; Munoz P; Rodriguez CG; Caliz B; Padilla B; Fernandez-Cruz A; Sanchez-Somolinos M; Gijon P; Peral J, COMIC Study Group Collaborative Group on Mycosis. Antifungal stewardship in a tertiary-care institution: a bedside intervention. CLINICAL MICROBIOLOGY AND INFECTION. 2015; 21(5) -9. FI: 4,575. Cuartil: 1. (Article).
9. Martinez-Laperche C; Noriega V; Kwon M; Balsalobre P; Gonzalez-Rivera M; Serrano D; Anguita J; Gayoso J. Achievement of early complete donor chimerism in CD25(+)-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation. EXPERIMENTAL HEMATOLOGY. 2015; 43(1) 4-13. FI: 2,303. Cuartil: 3. (Article).
10. Valerio M, Muñoz P, Rodríguez-González C, Sanjurjo M, Guinea J, Bouza E; COMIC study group (Collaborative group on Mycosis). Training should be the first step toward an antifungal stewardship program. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA 2015; 33(4) 221-227. (Article).
11. Valerio M, Vena A, Bouza E, Reiter N, Viale P, Hochreiter M, Giannella M, Muñoz P; COMIC study group (Collaborative group on Mycosis). How much European prescribing physicians know about invasive fungal infections management? BIOMED CENTRAL INFECTIOUS DISEASES. 2015; 15 80-87. (Article).
12. Olmedo C; Buño I; Pla R; Lomba I; Bardinet T; Banares R. Managing a health research institute: towards research excellence through continuous improvement. GACETA SANITARIA. 2015; 29(6) 458-460. FI: 1,509. Cuartil: 3. (Article).
13. Olmedo C, Plá R, Bellón JM, Bardinet T, Buño I, Bañares R. La investigación biomédica hospitalaria a través de la satisfacción de los profesionales de un Instituto de Investigación Sanitaria. REV CALID ASIST. 2015; 30 265-272. (Article).
14. Gómez AM, Martínez-Laperche C, González M, Luque A, Melen GJ, Martínez J, Hortelano S, Lassaletta Á, Madero L, Ramírez M. Chemokines and relapses in childhood acute lymphoblastic leukemia: A role in migration and in resistance to antileukemic drugs. BLOOD CELLS MOLECULES AND DISEASES 2015; 55(3) 220-227. FI: 2.331. Cuartil: 2. (Article).
15. de Lorenzo-Pinto A1, García-Sánchez R, Pascual Izquierdo C, Durán-García ME, Castuera-Gil AI, Andueza-Lillo JA, Sanjurjo-Sáez M. Impact of the ENDORSE study results on thromboprophylaxis prescribing patterns in medical patients attending the emergency department. INT J CLIN PRACT 2015; 69(1) 81-86. FI: 2.566. Cuartil: 1. (Article).
16. González-Porras JR, Mingot-Castellano ME, Andrade MM, Alonso R, Caparrós I, Arratibel MC, Fernández-Fuertes F, Cortti MJ, Pascual C, Sánchez-González B, Bernat S, Fuertes-Palacio MA, Vázquez-Paganini JA, Olivera PE, Alvarez-Román MT, Jarque I, Cortés M, Martínez-Robles V, Díaz-Gálvez FJ, Calbacho M, Fernández-Miñano C, Garcia-Frade J, González-López TJ. Use of eltrombopag after romiplostim in primary immune thrombocytopenia. BR J HAEMATOL. 2015; 169(1) 111-16. FI: 4.971. Cuartil: 1. (Article).
17. González-López TJ, Pascual C, Álvarez-Román MT, Fernández-Fuertes F, Sánchez-González B, Caparrós I, Jarque I, Mingot-Castellano ME, Hernández-Rivas JA, Martín-Salces M, Solán L, Beneit P, Jiménez R, Bernat S, Andrade MM, Cortés M, Cortti MJ, Pérez-Crespo S, Gómez-Núñez M, Olivera PE, Pérez-Rus G, Martínez-Robles V, Alonso R, Fernández-Rodríguez A, Arratibel MC, Perera M, Fernández-Miñano C, Fuertes-Palacio MA, Vázquez-Paganini JA, Gutierrez-Jomarrón I, Valcarce I, de Cabo E, Sainz A, Fisac R, Aguilar C, Paz Martínez-Badas M, Peñarrubia MJ, Calbacho M, de Cos C, González-Silva M, Coria E, Alonso A, Casaus A, Luaña A, Galán P, Fernández-Canal C, Garcia-Frade J, González-Porras JR. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia. AM J HEMATOL. 2015; 90(3) 40-43. FI: 3.978. Cuartil: 1. (Article).
18. González-López TJ, Sánchez-González B, Pascual C, Arefi M, de Cabo E, Alonso A, Martín-Salces M, Jiménez-Bárcenas R, Calbacho M, Galan P, Barez A, González-Porras JR. Sustained response after discontinuation of short-and medium-term treatment with eltrombopag in patients with immune thrombocytopenia. PLATELETS. 2015; 26(1) 83-86. FI: 2.982. Cuartil: 2. (Article).
19. Hidalgo Gamarra M, Rodríguez-Macías G, Escudero Soto A, Ortiz FJ, Vidán Astiz MT. [Disseminated bullous lesions and supraclavicular adenopathy in a nonagenarian patient]. REVISTA ESPAÑOLA DE GERIATRÍA Y GERONTOLOGÍA 2015; 50(1) 43-44. (Article).
20. Sanchez-Castro J; Marco-Betes V; Gomez-Arbones X; Garcia-Cerecedo T; Lopez R; Talavera E; Fernandez-Ruiz S; Adema V; Marugan I; Luno E; Sanzo C; Vallespi T; Arenillas L; Marco-Buades J; Batlle A; Buño I; Martin-Ramos ML; Blazquez-Rios B; Collado-Nieto R;. Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes. LEUKEMIA & LYMPHOMA. 2015; 56(11) 3183-3188. FI: 3,093. Cuartil: 2. (Article).
21. Ferra C; Sanz J; Diaz-Perez MA; Morgades M; Gayoso J; Cabrera JR; Villaescusa T; Sampol MA; Fernandez-Aviles F; Solano C; Ortin M; Duarte R; Cuesta M; Heras I; de la Serna J; Moraleda JM; Barrenetxea C; Gonzalez-Vicent M; Sanz G; Ribera JM. Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients. LEUKEMIA & LYMPHOMA. 2015; 56(3) 656-662. FI: 3,093. Cuartil: 2. (Article).
22. Noriega V; Martinez-Laperche C; Buces E; Pion M; Sanchez-Hernandez N; Martin-Antonio B; Guillem V; Bosch-Vizcaya A; Bento L; Gonzalez-Rivera M; Balsalobre P. The Genotype of the Donor for the (GT)(n) Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation. PLOS ONE. 2015; 10(10). FI: 3,057. Cuartil: 1. (Article).
23. Martino R; Bautista G; Parody R; Garcia I; Esquirol A; Rovira M; Cabrera JR; Regidor C; Fores R; Garcia-Marco JA; Serrano D; Barba P; Heras I; Marquez-Malaver FJ; Sanchez-Ortega I; Duarte R; Saavedra S; Sierra J; Vazquez L. Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34(+) cells from a third-party donor: results of a multicenter study from the Grupo Espanol de Trasplante Hematopoyetico (GETH). TRANSPLANT INFECTIOUS DISEASE. 2015; 17(2) 221-233. FI: 1,459. Cuartil: 3. (Article).
24. Bosch-Vizcaya A; Rodriguez-Romanos R; Nieto JB; de la Camara R; Brunet S; Vallejo C; Osca-Gelis G; Martinez-Laperche C; Buño I; Urbano-Ispizua A; Gonzalez M; Jimenez-Velasco A; Gallardo D. Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT. BONE MARROW TRANSPLANTATION. 2015; 50(2) 298-300. FI: 3,636. Cuartil: 2. (Letter).
25. Adema V; Larrayoz MJ; Calasanz MJ; Palomo L; Patino-Garcia A; Agirre X; Hernandez-Rivas JM; Lumbreras E; Buño I; Martinez-Laperche C; Mallo M; Garcia O; Alvarez S; Blazquez B; Cervera J; Luno E; Valiente A; Vallespi MT; Arenillas L; Collado R; Per. Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations. BRITISH JOURNAL OF HAEMATOLOGY. 2015; 171(1) 137-141. FI: 5,401. Cuartil: 1. (Letter).
26. Onaindia A; Gomez S; Piris-Villaespesa M; Martinez-Laperche C; Cereceda L; Montes-Moreno S; Batlle A; de Villambrosia SG; Pollan M; Martin-Acosta P; Gonzalez-Rincon J; Menarguez J; Alves J; Rodriguez-Pinilla SM; Garcia JF; Mollejo M; Fraga M; Garc. Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation. HAEMATOLOGICA. 2015; 100(5). FI: 6,671. Cuartil: 1. (Letter).
27. Barragan E; Chillon MC; Castello-Cros R; Marcotegui N; Prieto MI; Hoyos M; Pippa R; Llop M; Etxabe A; Cervera J; Rodriguez G; Buño I; Rifon J; Sierra J; Gonzalez M; Calasanz MJ; Sanz MA; Odero MD. CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia. HAEMATOLOGICA. 2015; 100(5). FI: 6,671. Cuartil: 1. (Letter).